Tissue Sealing Agents and Hemostasis – Product Types (Topical Hemostats, Mechanical Hemostats, Collagen Based , Oxidized Regenerated Cellulose Based , Gelatin Based , Polysaccharide Based , Active Hemostats – Thrombin-Based, Flowable Hemostats  – Combination, Adhesive and Tissue Sealing Agents, Natural Tissue Sealants, Fibrin Sealants, Other Natural Sealants – Albumin and Collagen Based, Synthetic Tissue Sealants, Cynoacrylate-Based Tissue Adhesives, Adhesion Barrier Products, Other Synthetic Tissue Sealant – Polyethylene Glycol Based) and Forecast 2017-2021

Tissue Sealing Agents and Hemostasis – Product Types (Topical Hemostats, Mechanical Hemostats, Collagen Based , Oxidized Regenerated Cellulose Based , Gelatin Based , Polysaccharide Based , Active Hemostats – Thrombin-Based, Flowable Hemostats  – Combination, Adhesive and Tissue Sealing Agents, Natural Tissue Sealants, Fibrin Sealants, Other Natural Sealants – Albumin and Collagen Based, Synthetic Tissue Sealants, Cynoacrylate-Based Tissue Adhesives, Adhesion Barrier Products, Other Synthetic Tissue Sealant – Polyethylene Glycol Based) and Forecast 2017-2021

An antihemorrhagic or tissue sealing agent is a substance that promotes hemostasis. Hemostasis or haemostasis is the first stage of wound healing a process which stops the bleeding. Hemostasis involves coagulation, blood changing from a liquid to a gel. Intact blood vessels are central to moderating blood’s tendency to form clots. A styptic or tissue sealing agent works by contracting tissue to seal injured blood vessels. Styptic pencils contain astringents. Antihemorrhagic agents used in medicine have various mechanisms of action such as, inhibiting fibrinolysis or promoting coagulation and vasoconstriction or promoting platelet aggregation.

The global tissue sealing agents and hemostasis market report provides market size (Revenue USD Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).

The global tissue sealing agents and hemostasis segmentation is based on product types (topical hemostats, mechanical hemostats, collagen based , oxidized regenerated cellulose based , gelatin based , polysaccharide based , active hemostats – thrombin-based, flowable hemostats  – combination, adhesive and tissue sealing agents, natural tissue sealants, fibrin sealants, other natural sealants – albumin and collagen based, synthetic tissue sealants, cynoacrylate-based tissue adhesives, adhesion barrier products, other synthetic tissue sealant such as polyethylene glycol based, etc.).

The global tissue sealing agents and hemostasis market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global tissue sealing agents and hemostasis market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Category:
  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue USD Million, 2014-2021)
    • Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Devices
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Device or Brand Type
    • Diagnostic Test
    • Indication Type
    • Technology
    • Diagnostics, Therapeutic or Surgical Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Regulatory Overview 
    • Device Classification I, II, III, IV
    • Device (FDA, EMEA) Approvals
  8. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  9. Recommendations
  10. References

Tissue Sealing Agents and Hemostasis Market

1. Product Type
1.1. Adhesive and Tissue Sealing Agents
1.1.1. Adhesion Barrier Products
1.1.2. Natural Tissue Sealants
1.1.2.1. Fibrin Sealants
1.1.2.2. Other Natural Sealants (Albumin and Collagen based)
1.1.3. Synthetic Tissue Sealants
1.1.3.1. Cynoacrylate-Based Tissue Adhesives
1.1.3.2. Other Synthetic Tissue Sealant (Polyethylene Glycol based, etc.)
1.2. Topical Hemostats
1.2.1. Active Hemostats (Thrombin-Based)
1.2.2. Flowable Hemostats (Combination)
1.2.3. Mechanical Hemostats
1.2.3.1. Collagen based
1.2.3.2. Oxidized Regenerated Cellulose (ORC) based
1.2.3.3. Gelatin based
1.2.3.4. Polysaccharide based

2. Geography (Region, Country)
2.1. North America (U.S., Canada)
2.2. Latin America (Brazil, Mexico, Rest of LA)
2.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4. Asia Pacific (Japan, China, India, Rest of APAC)
2.5. Rest of the World

3. Company Profiles
3.1. Advanced Medical Solutions Group plc
3.2. Baxter
3.3. Cohera Medical, Inc.
3.4. CryoLife, Inc.
3.5. C.R. Bard, Inc.
3.6. Johnson & Johnson Services, Inc.
3.7. Integra LifeSciences Corporation
3.8. Pfizer, Inc. 

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*

Translate »